Live search
TopFind is fetching the latest matches for your search.
We reviewed 264 live results for liquid glucagon and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Ivig and Pharmaceutical Services.
Sumber: Eli Lilly (Singapore) Pte Ltd
Deskripsi
Access to unregistered therapeutic products like Baqsimi in the Singapore market is managed through the Special Access Route (SAR) or Named Patient basis. This service involves physician-led requests for medications not currently listed on the standard Health Sciences Authority (HSA) retail market.
Paling cocok untuk
Singapore medical practitioners, patients with specific medical needs and unregistered drug import support
Penilaian
Sumber: Takeda Pharmaceuticals
Deskripsi
Gammagard Liquid is a 10% liquid immunoglobulin available for both intravenous (IVIG) and subcutaneous (SCIG) administration. It is indicated for PI, Multifocal Motor Neuropathy (MMN), and CIDP. The ERC version features enhanced removal capability for very low IgA content.
Paling cocok untuk
MMN patients, low IgA requirements, dual administration routes and PI therapy
Penilaian
Sumber: Takeda Malaysia
Deskripsi
An intravenous immunoglobulin treatment approved for the management of Primary Immunodeficiency (PI) and available in liquid form for infusion.
Paling cocok untuk
primary immunodeficiency, antibody replacement and immunology clinics
Penilaian
| Bandingkan | Special Access Route (SAR) Glucagon Access | Gammagard Liquid / Gammagard Liquid ERC | Gammagard Liquid |
|---|---|---|---|
| Sumber | Eli Lilly (Singapore) Pte Ltd | Takeda Pharmaceuticals | Takeda Malaysia |
| Deskripsi | Access to unregistered therapeutic products like Baqsimi in the Singapore market is managed through the Special Access Route (SAR) or Named Patient basis. This service involves physician-led requests for medications not currently listed on the standard Health Sciences Authority (HSA) retail market. | Gammagard Liquid is a 10% liquid immunoglobulin available for both intravenous (IVIG) and subcutaneous (SCIG) administration. It is indicated for PI, Multifocal Motor Neuropathy (MMN), and CIDP. The ERC version features enhanced removal capability for very low IgA content. | An intravenous immunoglobulin treatment approved for the management of Primary Immunodeficiency (PI) and available in liquid form for infusion. |
| Paling cocok untuk | Singapore medical practitioners, patients with specific medical needs and unregistered drug import support | MMN patients, low IgA requirements, dual administration routes and PI therapy | primary immunodeficiency, antibody replacement and immunology clinics |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Special Access Route (SAR) Glucagon Access from Eli Lilly (Singapore) Pte Ltd."
Saya memilih ini karena Eli Lilly is a key local contact for diabetes care in Singapore and can provide guidance on specialized access for their therapeutic portfolio.